CHICAGO EQUITY PARTNERS LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2019$2,508,000
-15.4%
49,640
-0.7%
0.10%
-19.2%
Q4 2018$2,964,000
-28.8%
49,995
-21.0%
0.12%
-1.6%
Q3 2018$4,165,000
+10.1%
63,275
-15.6%
0.12%
+5.2%
Q2 2018$3,784,000
-37.8%
74,940
-35.2%
0.12%
-40.2%
Q1 2018$6,084,000
+19.6%
115,560
+5.5%
0.19%
+25.2%
Q4 2017$5,088,000
+171.4%
109,490
+136.1%
0.16%
+162.7%
Q3 2017$1,875,000
+89.6%
46,365
+33.5%
0.06%
+110.7%
Q3 2015$989,00034,7250.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders